JUNCTIONAL EPIDERMOLYSIS BULLOSA
Clinical trials for JUNCTIONAL EPIDERMOLYSIS BULLOSA explained in plain language.
Never miss a new study
Get alerted when new JUNCTIONAL EPIDERMOLYSIS BULLOSA trials appear
Sign up with your email to follow new studies for JUNCTIONAL EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental gel aims to heal fragile skin in 'Butterfly Children'
Disease control Recruiting nowThis study is testing a gel called TCP-25 to see if it helps heal skin wounds in people with epidermolysis bullosa (EB), a condition that causes extremely fragile, blistering skin. In the trial, each participant will have two similar wounds treated—one with the TCP-25 gel and one…
Matched conditions: JUNCTIONAL EPIDERMOLYSIS BULLOSA
Phase: PHASE2 • Sponsor: Xinnate AB • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New gel offers hope for healing fragile skin in rare genetic condition
Disease control Recruiting nowThis study is testing whether Oleogel-S10 gel helps close wounds in people with two types of epidermolysis bullosa (EB), a rare genetic condition that causes fragile, blistering skin. Japanese children and adults with confirmed EB will apply the gel to their wounds for 45 days wh…
Matched conditions: JUNCTIONAL EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC